Fig. 5From: Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresisLeft panels show intense sclerotic features of cGVHD in hands and neck. Right panel shows some improvement in hands and nearly complete resolution in neck after ruxolitinib treatmentBack to article page